All articles tagged with #alnylam
City Therapeutics, a next-gen RNAi startup led by former Alnylam executives, has raised about $99.5 million to fund the clinical development and data collection for its first three RNAi medicines.
Alnylam Pharmaceuticals signed its first AI-driven discovery deal, paying a $30 million upfront to AI startup Inceptive to accelerate RNA research and development.
Roche's $3 billion deal with Alnylam for the rights to a hypertension treatment demonstrates a renewed interest from large pharmaceutical companies in developing long-acting heart drugs, as the cardiovascular disease market has been overshadowed by cancer and other diseases.